Petrucci Scatolini, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 3.256
AS - Asia 2.055
EU - Europa 2.032
SA - Sud America 400
AF - Africa 55
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.816
Nazione #
US - Stati Uniti d'America 3.157
SG - Singapore 907
DE - Germania 562
CN - Cina 513
IT - Italia 397
BR - Brasile 320
SE - Svezia 301
VN - Vietnam 168
FR - Francia 159
UA - Ucraina 133
GB - Regno Unito 118
IE - Irlanda 84
IN - India 76
FI - Finlandia 66
ID - Indonesia 66
BD - Bangladesh 63
CA - Canada 61
RU - Federazione Russa 57
HK - Hong Kong 49
TR - Turchia 45
JP - Giappone 40
AR - Argentina 33
BE - Belgio 25
NL - Olanda 23
CZ - Repubblica Ceca 22
IQ - Iraq 22
AT - Austria 19
KR - Corea 19
ES - Italia 18
MX - Messico 17
ZA - Sudafrica 16
PK - Pakistan 15
EC - Ecuador 13
AU - Australia 12
IR - Iran 12
PL - Polonia 12
PH - Filippine 11
SA - Arabia Saudita 11
CI - Costa d'Avorio 8
VE - Venezuela 8
CH - Svizzera 7
CL - Cile 6
LV - Lettonia 6
CO - Colombia 5
EG - Egitto 5
HN - Honduras 5
BG - Bulgaria 4
BO - Bolivia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
NI - Nicaragua 4
NO - Norvegia 4
NP - Nepal 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
NG - Nigeria 3
PE - Perù 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
TT - Trinidad e Tobago 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
Totale 7.811
Città #
Singapore 499
Ashburn 382
Chandler 290
San Jose 262
Los Angeles 104
Beijing 95
New York 90
Rome 88
Dublin 78
San Mateo 74
St Louis 73
Jacksonville 70
Milan 58
Nanjing 56
Cattolica 55
Jakarta 55
Ho Chi Minh City 54
Ann Arbor 53
Munich 53
Wilmington 52
Dallas 51
Hefei 51
Lauterbourg 48
Hong Kong 45
Hanoi 41
Frankfurt am Main 39
Tokyo 38
Boston 36
Moscow 34
Buffalo 33
Dearborn 29
The Dalles 28
Houston 27
São Paulo 26
Woodbridge 26
Atlanta 25
Nürnberg 25
Santa Clara 25
Princeton 24
Chicago 23
Helsinki 22
Bremen 20
Brno 20
Brussels 20
Council Bluffs 20
Hounslow 20
Nanchang 20
Izmir 18
Toronto 18
Bareggio 17
Kent 17
Lawrence 17
Orem 17
Redwood City 17
Tianjin 17
London 16
Paris 16
Turku 16
Hyderabad 15
Seattle 15
Seoul 15
Denver 14
Fairfield 14
Montreal 14
Redmond 13
Shenyang 13
Amsterdam 12
Brooklyn 12
Vienna 12
Augusta 11
Da Nang 11
Hebei 11
Kunming 11
Nuremberg 11
Verona 11
Charlotte 10
Guangzhou 10
Phoenix 10
Belo Horizonte 9
Boardman 9
Busto Arsizio 9
Chennai 9
Lancaster 9
Manchester 9
Mexico City 9
Stockholm 9
Warsaw 9
Zhengzhou 9
Abidjan 8
Dhaka 8
Haiphong 8
Johannesburg 8
Mountain View 8
Shanghai 8
Baghdad 7
Bursa 7
Hangzhou 7
Istanbul 7
Jinan 7
Marseille 7
Totale 3.968
Nome #
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 684
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 346
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 333
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 265
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 228
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 193
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 179
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 174
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 173
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 172
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 170
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 169
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 163
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 156
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 149
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 144
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 140
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 128
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 125
Aspirin, stroke and drug-drug interactions 124
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 123
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 122
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 122
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 119
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 118
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 117
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 116
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 115
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 115
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 113
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 112
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 112
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 105
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 104
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 102
influence of local environment on the differentiation of neuronal stem cells engrafted onto the injured spinal cord 102
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 102
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 101
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation 98
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 97
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 95
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 91
Mesenchymal differentiation of glioblastoma stem cells 89
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 89
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 88
Pathophysiology of Thrombosis in Peripheral Artery Disease 88
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 86
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 80
Pathophysiology of Thrombosis in Peripheral Artery Disease 79
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 78
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 73
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 72
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 69
Mesenchymal differentiation of glioblastoma stem cells 62
Totale 7.923
Categoria #
all - tutte 29.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022390 40 18 5 24 30 10 10 85 14 19 59 76
2022/2023808 105 116 69 118 61 89 26 70 100 18 22 14
2023/2024507 15 108 19 58 44 46 31 16 15 25 51 79
2024/20251.066 28 24 68 49 103 30 17 81 136 88 252 190
2025/20263.374 392 87 214 324 422 122 500 121 198 238 168 588
2026/2027291 291 0 0 0 0 0 0 0 0 0 0 0
Totale 7.923